ARWR - Arrowhead Pharmaceuticals, Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Currency in USD
Earnings EstimateCurrent Qtr. (Mar 2020)Next Qtr. (Jun 2020)Current Year (2020)Next Year (2021)
No. of Analysts10101010
Avg. Estimate-0.11-0.07-0.29-0.57
Low Estimate-0.16-0.35-0.81-1.31
High Estimate0.010.571.20.66
Year Ago EPS0.240.210.69-0.29
Revenue EstimateCurrent Qtr. (Mar 2020)Next Qtr. (Jun 2020)Current Year (2020)Next Year (2021)
No. of Analysts10101010
Avg. Estimate21.74M28.66M107.62M104.56M
Low Estimate17.8MN/A54.45M40M
High Estimate36M92.8M257.8M231M
Year Ago SalesN/AN/A168.8M107.62M
Sales Growth (year/est)N/AN/A-36.20%-2.80%
Earnings History3/30/20196/29/20199/29/201912/30/2019
EPS Est.0.190.290.16-0.01
EPS Actual0.240.210.11-0.03
Difference0.05-0.08-0.05-0.02
Surprise %26.30%-27.60%-31.20%-200.00%
EPS TrendCurrent Qtr. (Mar 2020)Next Qtr. (Jun 2020)Current Year (2020)Next Year (2021)
Current Estimate-0.11-0.07-0.29-0.57
7 Days Ago-0.11-0.07-0.29-0.57
30 Days Ago-0.11-0.04-0.23-0.48
60 Days Ago-0.03-0.02-0.11-0.39
90 Days Ago-0.08-0.06-0.32-0.52
EPS RevisionsCurrent Qtr. (Mar 2020)Next Qtr. (Jun 2020)Current Year (2020)Next Year (2021)
Up Last 7 DaysN/AN/AN/AN/A
Up Last 30 DaysN/AN/AN/AN/A
Down Last 7 DaysN/AN/AN/AN/A
Down Last 30 DaysN/AN/AN/AN/A
Growth EstimatesARWRIndustrySectorS&P 500
Current Qtr.-145.80%N/AN/A-0.11
Next Qtr.-133.30%N/AN/A-0.02
Current Year-142.00%N/AN/A-0.06
Next Year-96.60%N/AN/A0.17
Next 5 Years (per annum)7.33%N/AN/A0.06
Past 5 Years (per annum)N/AN/AN/AN/A